Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Brain Tunnelgenix Technologies

Request full access

Produces non-invasive and continuous temperature measurement devices

Bridgeport, United StatesFounded 2006Biotech & Life Sciences

About Brain Tunnelgenix Technologies

Brain Tunnelgenix Technologies (BTT) Corp. is a medical technology company founded in 2006, centered on the discovery of the Brain Temperature Tunnel (BTT™). This discovery was made by Dr. M. Marc Abreu, a medical doctor and former faculty member at Yale University School of Medicine and Harvard Medical School. Dr. Abreu's research in brain thermodynamics led to the identification of a noninvasive pathway to measure brain temperature continuously. This was a significant development, as it historically required invasive methods.

The company's core technology is based on this biological patent for the BTT, a thermophysical pathway located between the eye and eyebrow that allows for the unimpeded transfer of thermal energy from the brain. BTT Corp. develops and licenses patented products that utilize this tunnel to track and modulate brain temperature. Its flagship product, the Abreu BTT™ 700 System, received FDA 510(k) clearance in 2010. This computer-based system uses a sensor placed on the skin over the BTT to monitor temperature continuously and noninvasively, intended for use during surgical procedures, in recovery rooms, and for intensive care and general patient monitoring. The company operates on a business model that includes the sale of its medical devices and the development of subscription services for managing and researching various health conditions.

The firm's primary clients are healthcare professionals, researchers, and medical institutions. BTT is also exploring applications in other markets such as sports, military, and general wellness. The company's technology is being applied to develop diagnostics and therapies for a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and ALS. By modulating brain thermodynamics, the company aims to induce heat shock proteins that could help refold misfolded proteins, a common factor in many neurodegenerative diseases. In June 2022, the company secured $29.3 million in venture funding to expand its research and development efforts.

Source: Dealroom company data

At a glance

Status
Operational
Employees
21
Open positions
None listed
Dealroom signal
59.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jun 2022 $29M $117M Oklahoma Rock Holdings, LLC ↗
LATE VCOther financing Jan 2022 $29M $117M Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Brain Tunnelgenix Technologies team growth

Brain Tunnelgenix Technologies's team grew 200% over the past year.

1-year team growth+200%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Brain Tunnelgenix Technologies in the Bridgeport ecosystem

Live from Dealroom

The Brain Tunnelgenix Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Oklahoma Rock Holdings, LLC

Other known investors1 additional known investor

  • Yale University
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇧🇷 Brazil64.3%
🇺🇸 United States35.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Brain Tunnelgenix Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Brain Tunnelgenix Technologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.